
A phase-II trial of alltransretinoic acid and low-dose cytosine arabinoside for the treatment of high-risk myelodysplastic syndromes
A. Venditti, A. Tamburini, F. Buccisano, M. T. Scimò, G. Del Poeta, L. Maurillo, M. C. Cox, E. Abruzzese, M. Tribalto, M. Masi, S. AmadoriVolume:
79
Langue:
english
Pages:
5
DOI:
10.1007/s002770050569
Date:
March, 2000
Fichier:
PDF, 78 KB
english, 2000